• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制糖原合成酶激酶-3β通过 CRM1 依赖性机制促进雄激素受体在前列腺癌细胞系中的核输出。

Inhibition of glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines.

机构信息

Institute of General Zoology and Endocrinology, Ulm University, Albert Einstein Allee 11, 89069 Ulm, Germany.

出版信息

J Cell Biochem. 2010 Apr 15;109(6):1192-200. doi: 10.1002/jcb.22500.

DOI:10.1002/jcb.22500
PMID:20127713
Abstract

The androgen receptor (AR) is a ligand-dependent transcription factor belonging to the steroid hormone receptor superfamily. Under normal conditions, in the absence of a ligand, the AR is localized to the cytoplasm and is actively transported into the nucleus upon binding of androgens. In advanced prostate cancer (PCa) cell lines, an increased sensitivity to dihydrotestosterone (DHT), enabling the cells to proliferate under sub-physiological levels of androgens, has been associated with increased stability and nuclear localization of the AR. There is experimental evidence that the glycogen synthase kinase-3beta (GSK-3beta), a multifunctional serine/threonine kinase is involved in estrogen and AR stability. As demonstrated in the following study by immunoprecipitation analysis, GSK-3beta binds to the AR forming complexes in the cytoplasm and in the nucleus. Furthermore, inhibition of GSK-3beta activity by pharmacological inhibitors like the maleimide SB216761, the chloromethyl-thienyl-ketone GSK-3 inhibitor VI or the aminopyrazol GSK-3 inhibitor XIII in cells grown in the presence of DHT triggered a rapid nuclear export of endogenous AR as well as of green fluorescent AR-EosFP. The nuclear export of AR following GSK-3beta inhibition could be blocked by leptomycin B suggesting a CRM1-dependent export mechanism. This assumption is supported by the localization of a putative CRM1 binding site at the C-terminus of the AR protein. The results suggest that GSK-3beta is an important element not only in AR stability but also significantly alters nuclear translocation of the AR, thereby modulating the androgenic response of human PCa cells.

摘要

雄激素受体(AR)是一种配体依赖性转录因子,属于甾体激素受体超家族。在正常情况下,在没有配体的情况下,AR 位于细胞质中,并在与雄激素结合后被主动转运到细胞核中。在晚期前列腺癌(PCa)细胞系中,对二氢睾酮(DHT)的敏感性增加,使细胞能够在低于生理水平的雄激素下增殖,这与 AR 的稳定性和核定位增加有关。有实验证据表明,糖原合酶激酶-3β(GSK-3β),一种多功能丝氨酸/苏氨酸激酶,参与雌激素和 AR 的稳定性。正如以下研究中的免疫沉淀分析所示,GSK-3β与 AR 结合形成细胞质和细胞核中的复合物。此外,在 DHT 存在下生长的细胞中,通过药理学抑制剂如马来酰亚胺 SB216761、氯甲基-噻吩基-酮 GSK-3 抑制剂 VI 或氨基吡唑 GSK-3 抑制剂 XIII 抑制 GSK-3β 活性,会触发内源性 AR 以及绿色荧光 AR-EosFP 的快速核输出。GSK-3β 抑制后 AR 的核输出可以被莱普霉素 B 阻断,表明存在 CRM1 依赖性的输出机制。这一假设得到了 AR 蛋白 C 末端存在假定的 CRM1 结合位点的定位的支持。结果表明,GSK-3β不仅是 AR 稳定性的重要组成部分,而且还显著改变了 AR 的核转位,从而调节人 PCa 细胞的雄激素反应。

相似文献

1
Inhibition of glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines.抑制糖原合成酶激酶-3β通过 CRM1 依赖性机制促进雄激素受体在前列腺癌细胞系中的核输出。
J Cell Biochem. 2010 Apr 15;109(6):1192-200. doi: 10.1002/jcb.22500.
2
Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer.抑制糖原合成酶激酶-3β可拮抗去势抵抗性前列腺癌中雄激素受体的配体非依赖性活性。
PLoS One. 2011;6(9):e25341. doi: 10.1371/journal.pone.0025341. Epub 2011 Sep 29.
3
Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.糖原合酶激酶-3β活性是前列腺癌中雄激素刺激基因表达所必需的。
Endocrinology. 2004 Jun;145(6):2941-9. doi: 10.1210/en.2003-1519. Epub 2004 Feb 26.
4
Inhibition of glycogen synthase kinase-3 in androgen-responsive prostate cancer cell lines: are GSK inhibitors therapeutically useful?雄激素反应性前列腺癌细胞系中糖原合酶激酶-3的抑制作用:糖原合酶激酶抑制剂具有治疗作用吗?
Neoplasia. 2008 Jun;10(6):624-34. doi: 10.1593/neo.08248.
5
Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations.亚凋亡浓度下靛玉红衍生物对 LNCaP 人前列腺癌细胞的增殖和雄激素作用。
Chem Biol Interact. 2011 Feb 1;189(3):177-85. doi: 10.1016/j.cbi.2010.11.008. Epub 2010 Nov 25.
6
GSK-3beta inhibition: at the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma.糖原合成酶激酶-3β抑制:处于Akt和mTOR组成性激活之间的十字路口,以增强套细胞淋巴瘤中细胞周期蛋白D1的蛋白质稳定性。
Cell Cycle. 2008 Sep 15;7(18):2813-6. doi: 10.4161/cc.7.18.6733. Epub 2008 Sep 5.
7
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer.PXD101 增强了激素治疗效果,并在前列腺癌的临床前模型中调节雄激素受体、HSP90 和 CRM1,防止了去势抵抗表型的发生。
Endocr Relat Cancer. 2013 May 21;20(3):321-37. doi: 10.1530/ERC-12-0240. Print 2013 Jun.
8
Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells.异黄酮对前列腺癌细胞中Akt/FOXO3a/GSK-3β/AR信号网络的调控
J Biol Chem. 2008 Oct 10;283(41):27707-27716. doi: 10.1074/jbc.M802759200. Epub 2008 Aug 7.
9
Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.糖原合酶激酶-3β在成年大鼠心室肌细胞β-肾上腺素能受体刺激的凋亡中发挥促凋亡作用:β1整合素的作用
J Mol Cell Cardiol. 2007 Mar;42(3):653-61. doi: 10.1016/j.yjmcc.2006.12.011. Epub 2006 Dec 29.
10
GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells.糖原合成酶激酶-3β通过调节前列腺癌细胞中的肝脏激酶B1-腺苷酸活化蛋白激酶信号通路来控制自噬。
Prostate. 2016 Feb;76(2):172-83. doi: 10.1002/pros.23106. Epub 2015 Oct 6.

引用本文的文献

1
Androgen deprivation induces double-null prostate cancer via aberrant nuclear export and ribosomal biogenesis through HGF and Wnt activation.雄激素剥夺通过 HGF 和 Wnt 激活诱导双缺失前列腺癌通过异常核输出和核糖体生物发生。
Nat Commun. 2024 Feb 9;15(1):1231. doi: 10.1038/s41467-024-45489-4.
2
Re-Expression of ERα and AR in Receptor Negative Endocrine Cancers GSK3 Inhibition.雌激素受体α(ERα)和雄激素受体(AR)在受体阴性内分泌癌中的重新表达:糖原合成酶激酶3(GSK3)抑制作用
Front Oncol. 2022 Mar 24;12:824594. doi: 10.3389/fonc.2022.824594. eCollection 2022.
3
Transportin-2 plays a critical role in nucleocytoplasmic shuttling of oestrogen receptor-α.
转运蛋白-2在雌激素受体-α的核质穿梭中发挥着关键作用。
Sci Rep. 2020 Oct 29;10(1):18640. doi: 10.1038/s41598-020-75631-3.
4
Glycogen Synthase Kinase 3β in Cancer Biology and Treatment.糖原合酶激酶 3β在癌症生物学和治疗中的作用。
Cells. 2020 Jun 3;9(6):1388. doi: 10.3390/cells9061388.
5
A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer.GSK3β蛋白的核转位是前列腺癌的一个独立预后因素。
Oncotarget. 2019 Mar 1;10(18):1729-1744. doi: 10.18632/oncotarget.26739.
6
Impaired Nuclear Export of Polyglutamine-Expanded Androgen Receptor in Spinal and Bulbar Muscular Atrophy.脊髓性肌萎缩症和延髓性肌萎缩症中多聚谷氨酰胺扩展型雄激素受体核输出功能障碍。
Sci Rep. 2019 Jan 15;9(1):119. doi: 10.1038/s41598-018-36784-4.
7
Aberrant GSK3β nuclear localization promotes AML growth and drug resistance.异常的 GSK3β 核定位促进 AML 的生长和耐药性。
Blood Adv. 2018 Nov 13;2(21):2890-2903. doi: 10.1182/bloodadvances.2018016006.
8
Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer.使用核输出抑制剂进行药物治疗可增强多西他赛对人前列腺癌的抗肿瘤活性。
Oncotarget. 2017 Nov 30;8(67):111225-111245. doi: 10.18632/oncotarget.22760. eCollection 2017 Dec 19.
9
Modulation of glycogen synthase kinase-3β following TRAIL combinatorial treatment in cancer cells.TRAIL联合治疗癌细胞后糖原合酶激酶-3β的调节
Oncotarget. 2016 Oct 11;7(41):66892-66905. doi: 10.18632/oncotarget.11834.
10
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.KPT-330是一种强效且具有选择性的核输出蛋白1(XPO-1)抑制剂,在前列腺癌模型中显示出通过调节细胞周期蛋白D1和生存素的表达发挥抗肿瘤作用。
BMC Cancer. 2015 Dec 1;15:941. doi: 10.1186/s12885-015-1936-z.